MARKET

CERS

CERS

Cerus Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.01
+0.19
+3.94%
After Hours: 5.09 +0.08 +1.60% 19:06 04/08 EDT
OPEN
4.900
PREV CLOSE
4.820
HIGH
5.25
LOW
4.835
VOLUME
2.20M
TURNOVER
--
52 WEEK HIGH
6.64
52 WEEK LOW
2.710
MARKET CAP
812.45M
P/E (TTM)
-9.8255
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CERS stock price target is 8.00 with a high estimate of 9.50 and a low estimate of 7.00.

EPS

CERS News

More
  • Introducing Cerus (NASDAQ:CERS), The Stock That Dropped 26% In The Last Year
  • Simply Wall St. · 1d ago
  • My Top Four COVID-19 Tickers For Consideration
  • Seeking Alpha - Article · 2d ago
  • Cerus Corporation Provides Update on COVID-19 Related Activities
  • Business Wire · 2d ago
  • FDA Says Some Limited Data To Suggest Convalescent Plasma & Hyperimmune Globulin May Have Benefit In Coronavirus
  • Reuters · 5d ago

Industry

Medical Equipment, Supplies & Distribution
+4.22%
Healthcare Equipment & Supplies
+4.03%

Hot Stocks

Symbol
Price
%Change

About CERS

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
More

Webull offers kinds of Cerus Corporation stock information, including NASDAQ:CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions.